Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: Two case reports

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Montella, Liliana ^a   Addeo, Raffaele ^a   Faiola, Vincenzo ^a   Cennamo, Gregorio ^a   Guarrasi, Rosario ^a   Capasso, Elena ^b   Mamone, Rosanna ^a   Michele, Caraglia ^c   Del Prete, Salvatore ^a  

^a SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^b Senology Unit   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; APRACLONIDINE; IFOSFAMIDE; MESNA; ZOLEDRONIC ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE;

ADULT; AGED; ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PAIN; CANCER RADIOTHERAPY; CASE REPORT; CHONDROSARCOMA; CHORDOMA; CONTROLLED STUDY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SACRUM; TREATMENT RESPONSE; CANCER STAGING; CHONDROMA; COMPUTER ASSISTED TOMOGRAPHY; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; SPINAL CORD TUMOR;

AGED; ANTINEOPLASTIC AGENTS; CHONDROMA; CHONDROSARCOMA; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; NEOPLASM STAGING; SACRUM; SPINAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 66249148692     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-7     Document Type: Article

References (15)

1. Sarcoma of the soft tissue and bone. MF Brennan KM Alektiar RG Maki, Cancer: principles & practice of oncology Philadelphia: Lippincott Williams & Wilkins, De Vita VT, Hellman S, Rosenberg SA, 2001 1922 1929
2. Chordoma of the lumbar spine: a case report. H Tuna V Aydin M Bozkurt A Attar, Neurocirurgia 2005 16 2 169 72 15915306
3. Bisphosphonates: Preclinical review. JR Green, The Oncologist 2004 9 Suppl4 3 13 10.1634/theoncologist.9-90004-3
4. Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. JR Green K Muller KA Jaeggi, J Bone Miner Res 1994 9 745 751 8053405
5. Pamidronate Induces Modifications of Circulating Angiogenetic Factors in Cancer Patients. D Santini B Vincenzi G Avvisati D Dicuonzo F Battistoni M Gavasci A Salerno V Denaro G Tonini, Clin Cancer Res 2002 8 1080 4 12006522
6. Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. D Heymann B Ory F Blanchard MF Heymann P Coipeau C Charrier S Couillaud JP Thiery F Gouin F Redini, Bone 2005 37 74 86 10.1016/j.bone.2005.02.020 15894525
7. Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice. B Ory MF Heymann A Kamijo F Gouin D Heymann F Redini, Cancer 2005 104 2522 9 10.1002/cncr.21530 16270320
8. Anticancer effects of zoledronic acid against human osteosarcoma cells. B Kubista K Trieb F Sevelda C Toma F Arrich P Heffeter L Elbling H Sutterlüty K Scotlandi R Kotz M Micksche W Berger, J Orthop Res 2006 24 1145 52 10.1002/jor.20129 16602111
9. Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma. Z Zhou H Guan X Duan ES Kleinerman, Cancer 2005 104 1713 20 10.1002/cncr.21383 16121404
10. Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma. N Horie H Murata S Kimura H Takeshita T Sakabe T Matsui T Maekawa T Kubo S Fushiki, Br J Cancer 2007 96 255 61 10.1038/sj.bjc.6603548 17242698
11. Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. F Gouin B Ory F Redini D Heymann, Int J Cancer 2006 119 980 4 10.1002/ijc.21951 16570273
12. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status. B Ory F Blanchard S Battaglia F Gouin F Rédini D Heymann, Mol Pharmacol 2007 71 333 43 10.1124/mol.106.028837 17050806
13. Treatment of bone metastases and bone pain with bisphosphonates. A Lipton, Support Cancer Ther 2007 9 92 100 10.3816/SCT.2007.n.003
14. Rapid and sustained influence of intravenous zoledronic Acid on course of pain and analgesics consumption in patients with cancer with bone metastases: a multicenter open-label study over 1 year. A Kretzschmar T Wiege SE Al-Batran HF Hinrichs M Kindler T Steck HJ Illiger V Heinemann K Schmidt U Haus A Kirner G Ehninger, Support Cancer Ther 2007 4 203 10 10.3816/SCT.2007.n.016 18632518
15. Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report. R Addeo V Nocera V Faiola B Vincenzi G Ferraro L Montella R Guarrasi E Rossi G Cennamo G Tonini E Capasso D Santini M Caraglia S Del Prete, Support Care Cancer 2008 16 209 14 10.1007/s00520-007-0315-y 17701225